European Antibiotic Awareness Day: Rates of carbapenem-resistant infections continue to increase in Europe
On the occasion of the 6th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing new EU-wide data on antibiotic resistance showing a marked increase of carbapenem-resistant infections.
The proportion of Klebsiella pneumoniae bloodstream infections that is resistant to carbapenems has increased between 2009 and 2012, to above 5% in 5 countries, mostly in the south of Europe. A new serious concern is the emergence and spread of carbapenem-resistant Acinetobacter species, which is above 25% in 8 of 18 countries reporting data. This indicates even more seriously limited options for treatment of patients with Acinetobacter infections.
Together with EARS-Net annual report, ECDC is releasing the results of a survey based on a self-assessment by national experts from 38 countries of carbapenems-resistant infections in Europe, done for ECDC by the University Medical Centre in Groningen, in the Netherlands. The results indicate that the spread of carbapenem-resistant infections is much wider than indicated by EARS-Net, which only includes the most severe infections, i.e. bloodstream infections. If other infections, such as respiratory and urinary tract infections, are also considered, then almost all countries have reported cases, and many countries have reported regional and inter-regional spread, or even an endemic situation.
As part of the same survey, experts were also asked to report on the availability of national guidance documents for the control of carbapenem-resistant infections. Slightly more than half of the participating countries have such national guidance documents in place. The majority of these are countries that reported outbreaks, a regional spread or an endemic situation. However, 17 of the 38 participating countries still lack guidance for control of carbapenem-resistant infections, and only 2 countries reported having specific guidance to deal with carbapenem-resistant Acinetobacter infections.
To mark European Antibiotic Awareness Day on 18 November, more than 40 countries across Europe organise activities promoting prudent use of antibiotics under the banner “Everyone is responsible” during the week 18-24 November. ECDC is also cooperating with its partners in other regions of the world: campaigns on prudent antibiotic use are taking place in the United States, Canada and Australia during the same week.
Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe
1 Apr 2019 - ECDC comment on the study 'Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018' by Eyre et al. in the Eurosurveillance edition of 7 March 2019.
Gonorrhoea: drug resistance compromises recommended treatment in Europe
28 Feb 2019 - Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme.
Zoonoses: antimicrobial resistance shows no signs of slowing down
26 Feb 2019 - Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.